FDA Ghana Disclaims Approval of COA 72 for HIV Clinical Trials
The Food and Drugs Authority (FDA) Ghana has strongly denied reports suggesting it approved clinical trials for COA 72 as an HIV treatment. In an official statement, the agency emphasized that no such approval has been granted and warned that misleading health claims can endanger public safety and violate regulatory standards.
Read More